• Outlook,
• ICal,
• Google Calendar

Personalized medicine offers an exciting prospect for prevention, diagnostics and treatments by tailoring interventions to patient’s genomic profiles. However, translating discoveries into care for allis complex and requires overcoming of not only operational and financial hurdles, but also ethical, legal, and evidence-generation challenges.

Genomic data can only be collected, managed and used effectively if there is trust, appropriate infrastructure and training. This needs strong, transparent governance to balance patients and research needs.

How might personalized medicine transform health systems? How can we ensure equitable access to costly advanced therapies and diagnostics? What are the key considerations for decision makers? Join us to find out!

Speakers:

Yulia Litvinova, Technical University of Berlin / European Observatory on Health Systems and Policies, Germany (Keynote)

Ebba Hallersjö Hult, Stockholm School of Economics, Sweden

Matteo Gentili, Fondazione Toscana Life Sciences, Italy

Moderators: Dimitra Panteli & Erica Richardson (European Observatory on Health Systems and Policies)